Home / Inspections / 1194222

FDA Inspection 1194222 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 2276020

The FDA completed an inspection of New York Blood Center, Inc. on December 19, 2022 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 19, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
New Brunswick, NJ (United States)

Facility

Other inspections at this facility

  • 1094266 (NAI Mon Jun 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009901 (NAI Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903225 (NAI Fri Nov 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 831324 (NAI Fri May 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 751007 (NAI Wed Oct 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources